Shunji Nakajima
R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
ORCID: 0000-0002-9864-6111- Papers in database
- 3
- Years active
- 2018 – 2020
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (3)
- 2020Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action10.12938/bmfh.2019-022
- 2020The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin10.1080/19490976.2020.1758290
- 2018Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis10.12938/bmfh.18-020